Optain Health, a world leader in artificial intelligence-enabled medical technologies is expanding its global footprint in Victoria.
Optain is a healthcare technology company applying AI, robotic retinal imaging, and teleophthalmology to detect eye and systemic disease earlier. Its technology enables earlier detection of health conditions such as diabetic retinopathy, glaucoma, age-related macular degeneration, and even cardiovascular disease risk – all from a simple, non-invasive eye test, using a portable robotic camera and integrated AI workflows.
The company's expansion in Victoria will enable it to develop new AI applications for more accurate, rapid and efficient detection of a wider range of conditions, while unlocking the potential of oculomics – the science of using the eye as a window into whole-body health.
“Melbourne offers a unique combination of world-class technology talent, proactive government support, and a proven track record of exporting breakthrough products globally. That’s why we’re proud to make Victoria the permanent home for our global R&D team.”
Jeff Dunkel, CEO, Optain
Melbourne is as a national hub for AI in medical innovation with the Melbourne CBD now home to 188 AI companies and about 22 per cent of all clustered Australian AI firms – the most significant single AI cluster in the country.
Optains groundbreaking technology was first developed here in Victoria and has since scaled internationally. It recently launched into the United States with the backing of global software investor Insight Partners and seven major U.S. health system strategic investors.
Invest Victoria supported Optain’s entry into the Australian market. Working with The Victorian Government Trade and Investment office in Boston, they played a crucial role in assisting them connect further into the local ecosystem and explore appropriate funding and location options.
Optain’s APAC headquarters and R&D and Engineering Hub will deepen partnerships and collaboration across Victorian industry, universities and government, setting them on the right trajectory for growth.
“We’re thrilled to be deepening our investment in Victoria’s world-class AI and scientific ecosystem. As Australia makes research translation and productivity growth a national priority, we’re proud to be exporting local AI innovation into global healthcare impact.”
Dr. Zachary Tan, President, Optain
Learn more about medtech and pharma investment opportunities in Victoria.
